美股市场个股详情

SHTDY 国药控股(ADR)

添加自选

12.535
+0.015+0.12%

延时15分钟行情交易中 05/03 10:22 (美东)

78.23亿总市值6.26市盈率TTM

国药控股(ADR)股票讨论区

登录发表评论

Moomoo AI

03/27 06:49

Analysts have downgraded their earnings per share estimates for Sinopharm Group, indicating a decline in sentiment. They also suggest that Sinopharm may underperform compared to the wider industry, but the consensus price target remains steady.

Earnings Update: Sinopharm Group Co. Ltd. (HKG:1099) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts

让子弹飞（SG)

03/13 10:56

$国药控股(01099.HK)$ *大和首予國藥(01099.HK)「買入」評級目標價25元

Moomoo AI

03/13 07:10

Sinopharm Group's declining ROCE trend is concerning. Increased capital investment without matching sales suggests long-term plays. High current liabilities to total assets ratio introduces risk. These trends indicate Sinopharm may not be a multi-bagger.

Sinopharm Group (HKG:1099) Will Be Hoping To Turn Its Returns On Capital Around

Spinee

01/17 16:21

HSI Plunge Once Deepens to 620 Pts; Pharmas In Sell-off

$恒生指数(800000.HK)$ plunge deepened unceasingly after midday. It once stumbled 620 pts or 3.9% to bottom at 15,245, hitting an over-14-month low; last at 15,320, down 545 pts or 3.4%, with a total turnover of $88.5 billion.
Pharmaceuticals were sold off. $荣昌生物(09995.HK)$ once collapsed 27.5% to $22.8; last at $24.9, down 21%.
$三叶草生物-B(02197.HK)$ nosedived 9.6% to $0.47, hitting record low. $维亚生物(01873.HK)$ ...

Moomoo AI

01/16 06:51

Sinopharm Group's low P/E ratio is due to investors' limited growth expectations, leading to a reduced stock price. The poor earnings outlook from analysts also contributes to its low P/E. These conditions may continue to hinder the share price.

Investors Don't See Light At End Of Sinopharm Group Co. Ltd.'s (HKG:1099) Tunnel

Moomoo AI

2023/12/31 08:32

Sinopharm Group is currently undervalued and it might be a good time to accumulate more holdings in the stock. The positive outlook on the horizon of the company's future seems not to be fully factored into the current share price.

Why Sinopharm Group Co. Ltd. (HKG:1099) Could Be Worth Watching

Moomoo AI

2023/11/01 07:29

The declining trend in Sinopharm Group's ROCE and the stock's 42% fall in the last five years doesn't inspire investor confidence. The article doesn't consider Sinopharm Group as a potential multi-bagger based on the present analysis.

Sinopharm Group (HKG:1099) May Have Issues Allocating Its Capital

Steven000

2023/04/27 17:21

专栏港股收评：恒指涨0.42% ，内险股大爆发，中国平安绩后涨超9%

$恒生指数(800000.HK)$ 、$国企指数(800100.HK)$ 上涨0.42%、0.32%，$恒生科技指数(800700.HK)$ 表现较弱，下跌0.26%。
今日，港股午后现快速拉升行情，恒指、国指午后维持涨势，收盘分别上涨0.42%和0.32%，恒生科技指数表现较弱下跌0.26%。南下资金全日净流入14.97亿港元，大市成交额为970亿港元。
盘面上，大型科技股涨跌不一，$快手-W(01024.HK)$ 涨超1%，$小米集团-W(01810.HK)$ 、$美团-W(03690.HK)$ 小幅上涨，$阿里巴巴-SW(09988.HK)$ 、$百度集团-SW(09888.HK)$ 跌近2%；险企首季一季报业绩大增，内险股全天强势领涨，中国平安绩后劲升9%表现十分亮眼；大型基建股拉升明显，中字头股表现较佳，军工股、黄金股、特斯拉概念股、香港本地银行股多数走俏。另一方面，半导体股、建材水泥股延续跌势...